NASDAQ
Abiomed, Inc. (ABMD) has a revenue compound annual growth rate of 18.30% over 5 years and 23.36% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.